Skip to main content
Premium Trial:

Request an Annual Quote

Genstruct Licenses Pathway Database from Jubilant Biosys

NEW YORK, April 27 (GenomeWeb News) - Jubilant Biosys, of Bangalore, India, said today that it has licensed its PathArt database of biochemical pathways to Genstruct for use in that company's drug discovery programs.


Genstruct will use the database to enhance its Molecular Epistemics platform for the discovery and definition of compound mechanism of action and biomarkers.


According to Jubilant, PathArt contains over 600 manually curated signaling, metabolic, and disease-specific pathways, including diseases such as cancer, arthritis, Alzheimer's, asthma, multiple sclerosis, Parkinson's, diabetes, and atherosclerosis.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.